Decision aids for people facing health treatment or screening decisions

Stacey D, Lewis KB, Smith M, Carley M, Volk R, Douglas EE, Pacheco-Brousseau L, Finderup J, Gunderson J, Barry MJ, Bennett CL, Bravo P, Steffensen K, Gogovor A, Graham ID, Kelly SE, Legare F, Sondergaard H, Thomson R, Trenaman L, Trevena L

Published January 29, 2024 Cochrane Database of Systematic Reviews
DOI 10.1002/14651858.CD001431.pub6 PMID 38284415 PMC PMC10823577

RRM Academy Synopsis

Decision aids probably help adults make informed, values-based choices

A 2024 Cochrane review of 209 randomized trials found that patient decision aids probably help more adults reach choices matching their informed values than usual care does. The trials enrolled 107,698 people, and the review reported high-certainty evidence of better knowledge.

Key Findings

  • Knowledge rose, with a mean difference of 11.90 on a 100-point scale (95% confidence interval 10.60 to 13.19) across 107 studies and 25,492 participants.
  • Risk perceptions became more accurate, with a risk ratio of 1.94 (95% confidence interval 1.61 to 2.34) across 25 studies and 7796 participants.
  • With moderate certainty, decision aids probably increase congruence between informed values and care choices, with a risk ratio of 1.75 (95% confidence interval 1.44 to 2.13) across 21 studies.
  • Across 58 studies, decisional conflict related to feeling uninformed fell (mean difference -10.02, 95% confidence interval -12.31 to -7.74). Across 55 studies, indecision about personal values fell (-7.86, -9.69 to -6.02).
  • Decision regret showed no difference between the decision aid and usual care groups, with a mean difference of -1.23 (95% confidence interval -3.05 to 0.59) across 22 studies and 3707 participants.

Interpretation

The synopsis rests on the published abstract of a systematic review of randomized controlled trials, because the full text was unavailable. The trials covered 71 different decisions, led by cardiovascular treatments, cancer screening, cancer treatments, mental health treatments and joint replacement surgery. The authors report the same direction of effect in earlier and newer studies. They state that further studies are needed on adherence, cost and resource use.

RRM Context

RRM pairs the evaluation of both partners with informed, shared decision-making. Knowing the facts, seeing risks clearly and holding clear values mark an informed choice in many areas of medicine, including reproductive care.

Abstract

Background

Patient decision aids are interventions designed to support people making health decisions. At a minimum, patient decision aids make the decision explicit, provide evidence-based information about the options and associated benefits/harms, and help clarify personal values for features of options. This is an update of a Cochrane review that was first published in 2003 and last updated in 2017.

Objectives

To assess the effects of patient decision aids in adults considering treatment or screening decisions using an integrated knowledge translation approach.

Search Methods

We conducted the updated search for the period of 2015 (last search date) to March 2022 in CENTRAL, MEDLINE, Embase, PsycINFO, EBSCO, and grey literature. The cumulative search covers database origins to March 2022.

Selection Criteria

We included published randomized controlled trials comparing patient decision aids to usual care. Usual care was defined as general information, risk assessment, clinical practice guideline summaries for health consumers, placebo intervention (e.g. information on another topic), or no intervention.

Data Collection and Analysis

Two authors independently screened citations for inclusion, extracted intervention and outcome data, and assessed risk of bias using the Cochrane risk of bias tool. Primary outcomes, based on the International Patient Decision Aid Standards (IPDAS), were attributes related to the choice made (informed values-based choice congruence) and the decision-making process, such as knowledge, accurate risk perceptions, feeling informed, clear values, participation in decision-making, and adverse events. Secondary outcomes were choice, confidence in decision-making, adherence to the chosen option, preference-linked health outcomes, and impact on the healthcare system (e.g. consultation length). We pooled results using mean differences (MDs) and risk ratios (RRs) with 95% confidence intervals (CIs), applying a random-effects model. We conducted a subgroup analysis of 105 studies that were included in the previous review version compared to those published since that update (n = 104 studies). We used Grading of Recommendations Assessment, Development, and Evaluation (GRADE) to assess the certainty of the evidence.

Main Results

This update added 104 new studies for a total of 209 studies involving 107,698 participants. The patient decision aids focused on 71 different decisions. The most common decisions were about cardiovascular treatments (n = 22 studies), cancer screening (n = 17 studies colorectal, 15 prostate, 12 breast), cancer treatments (e.g. 15 breast, 11 prostate), mental health treatments (n = 10 studies), and joint replacement surgery (n = 9 studies). When assessing risk of bias in the included studies, we rated two items as mostly unclear (selective reporting: 100 studies; blinding of participants/personnel: 161 studies), due to inadequate reporting. Of the 209 included studies, 34 had at least one item rated as high risk of bias. There was moderate-certainty evidence that patient decision aids probably increase the congruence between informed values and care choices compared to usual care (RR 1.75, 95% CI 1.44 to 2.13; 21 studies, 9377 participants). Regarding attributes related to the decision-making process and compared to usual care, there was high-certainty evidence that patient decision aids result in improved participants' knowledge (MD 11.90/100, 95% CI 10.60 to 13.19; 107 studies, 25,492 participants), accuracy of risk perceptions (RR 1.94, 95% CI 1.61 to 2.34; 25 studies, 7796 participants), and decreased decisional conflict related to feeling uninformed (MD -10.02, 95% CI -12.31 to -7.74; 58 studies, 12,104 participants), indecision about personal values (MD -7.86, 95% CI -9.69 to -6.02; 55 studies, 11,880 participants), and proportion of people who were passive in decision-making (clinician-controlled) (RR 0.72, 95% CI 0.59 to 0.88; 21 studies, 4348 participants). For adverse outcomes, there was high-certainty evidence that there was no difference in decision regret between the patient decision aid and usual care groups (MD -1.23, 95% CI -3.05 to 0.59; 22 studies, 3707 participants). Of note, there was no difference in the length of consultation when patient decision aids were used in preparation for the consultation (MD -2.97 minutes, 95% CI -7.84 to 1.90; 5 studies, 420 participants). When patient decision aids were used during the consultation with the clinician, the length of consultation was 1.5 minutes longer (MD 1.50 minutes, 95% CI 0.79 to 2.20; 8 studies, 2702 participants). We found the same direction of effect when we compared results for patient decision aid studies reported in the previous update compared to studies conducted since 2015.

Authors' Conclusions

Compared to usual care, across a wide variety of decisions, patient decision aids probably helped more adults reach informed values-congruent choices. They led to large increases in knowledge, accurate risk perceptions, and an active role in decision-making. Our updated review also found that patient decision aids increased patients' feeling informed and clear about their personal values. There was no difference in decision regret between people using decision aids versus those receiving usual care. Further studies are needed to assess the impact of patient decision aids on adherence and downstream effects on cost and resource use.

By this author

Related research

Dawn Stacey, Krystina B Lewis, Maureen Smith, Meg Carley, Robert Volk, Elisa E Douglas, Lissa Pacheco-Brousseau, Jeanette Finderup, Janet Gunderson, Michael J Barry, Carol L Bennett, Paulina Bravo, Karina Steffensen, Amédé Gogovor, Ian D Graham, Shannon E Kelly, France Legare, Henning Sondergaard, Richard Thomson, Logan Trenaman, Lyndal Trevena
D Stacey, K Lewis, M Smith, M Carley, Bob Volk, Rob Volk, Bobby Volk, R Volk, E Douglas, L Pacheco-Brousseau, J Finderup, J Gunderson, Mike Barry, M Barry, C Bennett, P Bravo, K Steffensen, A Gogovor, I Graham, S Kelly, F Legare, H Sondergaard, Rick Thomson, Dick Thomson, Rich Thomson, R Thomson, L Trenaman, L Trevena
PMID 38284415 38284415 DOI 10.1002/14651858.CD001431.pub6 10.1002/14651858.CD001431.pub6 Stacey et al. 2024, Stacey 2024